Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks
Common clinical goals for BPC-157 include: Supporting soft-tissue healing (tendons, ligaments, muscles, and fascia) after injury or overuse Promoting post-surgical recovery and tissue regeneration Reducing inflammation and associated pain in joints and musculoskeletal conditions Supporting gut lining integrity and symptoms related to gastric ulcers, IBS, or leaky gut Assisting recovery from sports-related injuries and enhancing exercise recovery Supporting blood flow to injured tissues to aid repair Adjunctive support for chronic pain related to tissue or nerve injury Addressing Common Misconceptions and Questions Surrounding BPC-157 Online discussions often include myths that can cloud understanding
BPC-157 speaks directly to that audience
Intrinsic Factor and Absorption Challenges As previously noted, intrinsic factor is a key player in B12 absorption, as it binds to the vitamin, allowing for proper absorption
A named specialist who knows your practice and protocol preferences
Glutathione and cadmium toxicity [PMID: 3064014] Laboratory literature summary: Glutathione and cadmium toxicity
)
